Table 3 Early Check rubric for categorizing molecular diagnoses

From: Feasibility and clinical utility of expanded genomic newborn screening in the Early Check program

Variant result (presumed zygosity)

Initial screen molecular interpretation (without variant confirmation)

Final molecular interpretation (after variant confirmation)

Autosomal recessive

  

Variants in trans

Variants in cis

Unable to confirm phase or N/A

P (hom.)

Probable molecular diagnosis

Definite molecular diagnosis

N/A

Probable molecular diagnosis

P/P (comp. het.)

Possible molecular diagnosis

Definite molecular diagnosis

False positive

Possible molecular diagnosis

LP (hom.)

Possible molecular diagnosis

Likely molecular diagnosis

N/A

Possible molecular diagnosis

P/LP (comp. het.)

Possible molecular diagnosis

Likely molecular diagnosis

False positive

Possible molecular diagnosis

LP/LP (comp. het.)

Possible molecular diagnosis

Likely molecular diagnosis

False positive

Possible molecular diagnosis

P (het.)

Probable carriera

N/A

N/A

Definite carrier

LP (het.)

Possible carriera

N/A

N/A

Likely carrier

P or LP and VUS (comp. het.)b

N/A

Uncertain

False positive

Uncertain

X-linked (female newborns)

P (hom.)

Probable molecular diagnosis

Definite molecular diagnosis

N/A

Probable molecular diagnosis

P/P (comp. het.)

Possible molecular diagnosis

Definite molecular diagnosis

False positive

Possible molecular diagnosis

LP (hom.)

Possible molecular diagnosis

Likely molecular diagnosis

N/A

Possible molecular diagnosis

P/LP (comp. het.)

Possible molecular diagnosis

Likely molecular diagnosis

False positive

Possible molecular diagnosis

LP/LP (comp. het.)

Possible molecular diagnosis

Likely molecular diagnosis

False positive

Possible molecular diagnosis

P (het.)

Probable molecular diagnosis or Probable carrierc

N/A

N/A

Definite molecular diagnosis or Definite carrierc

LP (het.)

Possible molecular diagnosis or Possible carrierc

N/A

N/A

Likely molecular diagnosis or Likely carrierc

LP or P and VUS (comp. het.)b

N/A

Uncertain

False positive

Uncertain

Autosomal dominant

P (het.)

Probable molecular diagnosis

Definite molecular diagnosis

LP (het.)

Possible molecular diagnosis

Likely molecular diagnosis

VUS (het.)b

N/A

Uncertain

X-linked (males)

P (hemi.)

Probable molecular diagnosis

Definite molecular diagnosis

LP (hemi.)

Possible molecular diagnosis

Likely molecular diagnosis

VUS (hemi.)b

N/A

Uncertain

  1. comp., compound; hemi., hemizygous; het., heterozygous; hom., homozygous.
  2. aHeterozygous P or LP variants in genes associated with autosomal recessive conditions are reportable only if the gene is also associated with an autosomal dominant condition (for example, ABCC8).
  3. bVUS are not reported on screening, but it is possible that an LP variant reported on screening could be downgraded to a VUS after confirmatory testing and familial segregation.
  4. cMolecular interpretation of heterozygous X-linked variants in females differs depending on whether female carriers can manifest symptoms.